[
  {
    "criterion": "Reward for accurately documenting in the HPI the patient-reported symptoms and concerns specific to this segment (increased hunger since starting glipizide, fear of weight gain, relief of ACE-inhibitor cough, new intermittent ankle swelling after starting losartan)",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for a clear Assessment/Plan that links each reported symptom to the corresponding medication, states probable causality, and outlines concrete next steps (e.g., monitor weight and blood sugars, reassess glipizide need, monitor ankle edema and consider losartan dose change/alternative)",
    "weight": 25,
    "sense": "positive"
  },
  {
    "criterion": "Reward for explicit patient-safety counseling and follow-up instructions\u2014documenting education about hypoglycemia signs, guidance to log blood sugars/weights, red-flag edema symptoms, and a defined timeframe or trigger for re-evaluation",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for evidence-based reasoning in medication management (notes glipizide\u2019s weight-gain risk vs. alternatives, confirms ARB use per guidelines after ACE cough, reinforces diet/exercise per ADA/ACC-AHA guidance)",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Penalize for omission of objective or quantifiable data relevant to the issues (current weight, recent home glucose readings, blood pressure, description/measurement of ankle edema, medication list reconciliation)",
    "weight": 10,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for inclusion of redundant, copy-pasted, or irrelevant content not directly related to this encounter segment",
    "weight": 10,
    "sense": "negative"
  }
]